Asterand Biosciences Overview

  • Founded
  • 2007

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 8

  • Investments
  • 4

Asterand Biosciences General Information

Description

Developer of innovative technology and reagents designed to simplify and support cellular reprogramming research. The company's innovative technology and reagents is a supplier of cellular reprogramming products and tissue-based research including tools for cell research which help in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media and iPS reprogramming services, enabling stem cell scientists to advance and improvise stem cell research.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Other Healthcare Services
Acquirer
Primary Office
  • 4 Hartwell Place
  • Lexington, MA 02421
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asterand Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Asterand Biosciences‘s full profile, request access.

Request a free trial

Asterand Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of innovative technology and reagents designed to simplify and support cellular reprogramming research. The co
Biotechnology
Lexington, MA
51 As of 2015
000.00
000000000000

000000

citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend
0000000000000
Littleton, MA
00 As of 0000
000.00
000000000. 0 000.00

000000

idunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco l
0000000000000
Oxford, United Kingdom
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Asterand Biosciences Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Provia Labs Accelerator/Incubator Backed Littleton, MA 00 000.00 000000000. 0 000.00
000000 Formerly VC-backed Oxford, United Kingdom 00 000.00 000000&0 000.00
00000000 000 Formerly VC-backed Somerville, MA 000 00000 000000000 00000
0000000 00000000 Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
00000000 Private Equity-Backed Alameda, CA 00 000000000000
You’re viewing 5 of 7 competitors. Get the full list »

Asterand Biosciences Patents

Asterand Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2015522257-A Methods for preparing pluripotent stem cells Pending 13-Jun-2012 0000000000
US-20150232810-A1 Methods of preparing pluripotent stem cells Abandoned 13-Jun-2012 0000000000
EP-2861612-A1 Methods of preparing pluripotent stem cells Withdrawn 13-Jun-2012 0000000000
EP-2861612-A4 Methods of preparing pluripotent stem cells Withdrawn 13-Jun-2012 0000000000 0
AU-2013274197-A1 Methods of preparing pluripotent stem cells Abandoned 13-Jun-2012 C12N5/0696
To view Asterand Biosciences’s complete patent history, request access »

Asterand Biosciences Executive Team (10)

Name Title Board Seat Contact Info
Rama Modali Chief Executive Officer
Peter Ferrigno Chief Commercial Officer
Stephen Chang Ph.D Co-Founder
Ian Ratcliffe Co-Founder
Sheng Ding Ph.D Co-Founder
You’re viewing 5 of 10 executive team members. Get the full list »

Asterand Biosciences Board Members (5)

Name Representing Role Since
000000 00000000 Self Board Member 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Asterand Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asterand Biosciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Asterand Biosciences‘s full profile, request access.

Request a free trial

Asterand Biosciences Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 18-Sep-2013 0000 00000 00000 Drug Discovery 000 00000
00000000 01-Aug-2012 0000000000 Laboratory Services (Healthcare)
00000000 (000 01-Aug-2012 0000000000 000 Other Devices and Supplies 000 00000
Ubiquigent 03-Mar-2010 Corporate Drug Discovery 000 00000
To view Asterand Biosciences’s complete investments and acquisitions history, request access »